Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients

Código QR

Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients

Guardado en:

Detalles Bibliográficos
Autores principales:	Santosh Kumar Sinha, Puneet Aggarwal, Umeshwar Pandey, Mahmodullah Razi, Awdesh Kumar, Vinay Krishna
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/681d2659c6544b4ba63a7d599f7a53ca
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina M, et al.
Publicado: (2011)

Procedural and short-term clinical outcomes post-PCI using newer generation ultrathin sirolimus-eluting stent with biodegradable polymer coating in real-world population
por: Pravin K. Goel, et al.
Publicado: (2021)

Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
por: Xinlin Zhang, et al.
Publicado: (2014)

Clinical outcomes of ultrathin biodegradable polymer-coated sirolimus-eluting stents in an all-comer population: One-year results from the T-FLEX registry including high-risk subgroups
por: Ramesh Babu Pothineni, et al.
Publicado: (2021)

Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
por: Basant Kumar, et al.
Publicado: (2021)

Real-world registry of the durable Angiolite fluoroacrylate polymer-based sirolimus-eluting stent: the EPIC02 – RANGO study
por: Armando Pérez de Prado, et al.
Publicado: (2021)

Everolimus-eluting coronary stents
por: Alejandro Saez, et al.
Publicado: (2010)

Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter Registry
por: Yi Dai, et al.
Publicado: (2021)

Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Cheng-Hung Lee, et al.
Publicado: (2017)

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study
por: Magdalena Dobrolińska, et al.
Publicado: (2020)

New drug-eluting stents: technological refinement continues
por: Javier Suárez de Lezo, et al.
Publicado: (2021)

Everolimus-eluting stents: update on current clinical studies
por: Allocco DJ, et al.
Publicado: (2011)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency
por: Rory Marples, MBBS, et al.
Publicado: (2022)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
por: Lee CH, et al.
Publicado: (2018)

Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
por: Kyriacos Papadopoulos, et al.
Publicado: (2021)

Advances in drug eluting stents &ndash; focus on the Endeavor&reg; zotarolimus stent
por: Jonathan Bridges, et al.
Publicado: (2008)

A Case of Stent Fracture and Very Late Stent Thrombosis 15 Months after Drug-Eluting Stent Implantation
por: A Ghaemian,, et al.
Publicado: (2009)

Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
por: Kim DH, et al.
Publicado: (2013)

Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
por: Brendan Doyle, et al.
Publicado: (2009)

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
por: Litsky J, et al.
Publicado: (2014)

Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
por: Khaled Alsayed
Publicado: (2020)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Yong Zhu, et al.
Publicado: (2021)

Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes
por: Panoulas VF, et al.
Publicado: (2015)

Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation.
por: Hiroyuki Jinnouchi, et al.
Publicado: (2021)

Impact of stent edge dissection detected by optical coherence tomography after current-generation drug-eluting stent implantation
por: Hiroyuki Jinnouchi, et al.
Publicado: (2021)

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
por: Bennett J, et al.
Publicado: (2013)

The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
por: Sanchez OD, et al.
Publicado: (2014)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Piotr Desperak, et al.
Publicado: (2020)

Impact of hospital and sociodemographic factors on utilization of drug-eluting stents in 2011-2012 Medicare cohort
por: Tushar A Tuliani, et al.
Publicado: (2017)

Drug diffusion and biological responses of arteries using a drug-eluting stent with nonuniform coating
por: Saito N, et al.
Publicado: (2016)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Josep Gomez‐Lara, et al.
Publicado: (2021)

Application of galangin, an active component of Alpinia officinarum Hance (Zingiberaceae), for use in drug-eluting stents
por: Jung-Jin Lee, et al.
Publicado: (2017)

Safety and Efficacy of Rapamycin-Eluting Vertebral Stents in Patients With Symptomatic Extracranial Vertebral Artery Stenosis
por: Gaoting Ma, et al.
Publicado: (2021)

Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis.
por: Pascal Meier, et al.
Publicado: (2010)

Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery
por: Jinzhou Zhu, et al.
Publicado: (2021)

Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
por: Kwak TW, et al.
Publicado: (2017)

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
por: Lee CH, et al.
Publicado: (2019)

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold
por: Stefan Toggweiler, et al.
Publicado: (2021)

Early scaffold strut coverage in ultra-high molecular weight amorphous PLLA sirolimus-eluting bioresorbable scaffolds: impact of strut thickness assessed in normal porcine coronary arteries
por: Paweł Gąsior, et al.
Publicado: (2020)

Registro prospectivo del stent liberador de sirolimus con polímero estable de fluoroacrilato Angiolite: estudio EPIC02 – RANGO
por: Alberto Rodrigues, et al.
Publicado: (2021)